Compare CAPT & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CAPT | MBAI |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | South Korea | Israel |
| Employees | N/A | N/A |
| Industry | Blank Checks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 10.6M |
| IPO Year | N/A | N/A |
| Metric | CAPT | MBAI |
|---|---|---|
| Price | $0.42 | $1.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 152.1K | 50.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $1.31 |
| 52 Week High | $1.93 | $3.92 |
| Indicator | CAPT | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 50.28 |
| Support Level | $0.40 | $1.38 |
| Resistance Level | $0.46 | $1.89 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 43.40 | 56.60 |
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.